Interaction between topical miconazole and coumarins.
Broos
Nancy
N
van Puijenbroek
Eugène P
EP
D000279:Administration, Cutaneous; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000037:antagonists & inhibitors*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001189:Aryl Hydrocarbon Hydroxylases / Q000037:antagonists & inhibitors*; D003374:Coumarins / Q000037:antagonists & inhibitors*; D065729:Cytochrome P-450 CYP2C9; D004336:Drug Antagonism; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D008825:Miconazole / Q000008:administration & dosage / Q000494:pharmacology*; D008875:Middle Aged; D012869:Skin Absorption
D000925:Anticoagulants; D000935:Antifungal Agents; D003374:Coumarins; D004791:Enzyme Inhibitors; D008825:Miconazole; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases